Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap4.51B
Market cap4.51B
Price-Earnings ratio29.23
Price-Earnings ratio29.23
Dividend yield—
Dividend yield—
Average volume302.63K
Average volume302.63K
High today$156.25
High today$156.25
Low today$145.46
Low today$145.46
Open price$146.52
Open price$146.52
Volume797.97K
Volume797.97K
52 Week high$207.84
52 Week high$207.84
52 Week low$122.80
52 Week low$122.80
KRYS News
TipRanks 9h
Krystal Biotech announces FDA approval of update VYJUVEK labelKrystal Biotech (KRYS) announced that the United States Food and Drug Administration, FDA, approved a label update for VYJUVEK that expands the VYJUVEK eligible...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.